NasdaqCM - Delayed Quote USD

electroCore, Inc. (ECOR)

7.50

+0.33

(+4.60%)

At close: May 14 at 4:00 PM EDT

Key Events

Loading Chart for ECOR

9/21 12:03 PM

DELL

Previous Close 7.17
Open 7.20
Bid --
Ask --
Day's Range 7.20 - 7.80
52 Week Range 3.83 - 8.08
Volume 28,952
Avg. Volume 11,783
Market Cap (intraday) 45.02M
Beta (5Y Monthly) 0.92
PE Ratio (TTM) --
EPS (TTM) -3.42
Earnings Date Aug 7, 2024 - Aug 12, 2024
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est 23.10

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

www.electrocore.com

68

Full Time Employees

December 31

Fiscal Year Ends

Sector

Medical Devices

Industry

Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ECOR

26.01%

S&P 500

10.00%

1-Year Return

ECOR

15.21%

S&P 500

27.22%

3-Year Return

ECOR

67.95%

S&P 500

27.58%

5-Year Return

ECOR

91.26%

S&P 500

86.59%

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

electroCore, Inc.

7.50

+4.60%

Mkt Cap 45.02M

Industry Medical Devices

5.99

+4.72%

Mkt Cap 382.327M

Industry Medical Devices

16.68

-0.83%

Mkt Cap 455.176M

Industry Medical Devices

3.5800

-1.65%

Mkt Cap 103.156M

Industry Medical Devices

5.48

-0.36%

Mkt Cap 92.279M

Industry Medical Devices

Helius Medical Technologies, Inc.

1.5600

-8.24%

Mkt Cap 1.385M

Industry Medical Devices

Co-Diagnostics, Inc.

1.1200

+4.19%

Mkt Cap 35.011M

Industry Medical Devices

Intelligent Bio Solutions Inc.

2.3900

-0.83%

Mkt Cap 6.798M

Industry Medical Devices

Sensus Healthcare, Inc.

5.30

-1.85%

Mkt Cap 86.881M

Industry Medical Devices

NeuroPace, Inc.

8.51

-0.12%

Mkt Cap 244.817M

Industry Medical Devices

Profound Medical Corp.

8.21

+7.32%

Mkt Cap 200.561M

Industry Medical Devices

Valuation Measures

As of 5/13/2024

Market Cap

43.52M
Enterprise Value

37.33M
Trailing P/E

--
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

2.32
Price/Book (mrq)

9.68
Enterprise Value/Revenue

--
Enterprise Value/EBITDA

--

Financial Highlights

Profitability and Income Statement

Profit Margin

-117.49%
Return on Assets (ttm)

-57.53%
Return on Equity (ttm)

-153.57%
Revenue (ttm)

16.03M
Net Income Avi to Common (ttm)

-18.83M
Diluted EPS (ttm)

-3.42

Balance Sheet and Cash Flow

Total Cash (mrq)

10.33M
Total Debt/Equity (mrq)

8.41%
Levered Free Cash Flow (ttm)

-8.68M

ECOR does not have Company Insights

SONN Sonnet BioTherapeutics Holdings, Inc.

1.8100

0.00%

ALRN Aileron Therapeutics, Inc.

3.9000

+0.52%

ATHE Alterity Therapeutics Limited

2.1001

+1.95%

PRPO Precipio, Inc.

6.49

+3.34%

BOXL Boxlight Corporation

0.6010

-0.73%

DARE Daré Bioscience, Inc.

0.3150

-0.82%

COCP Cocrystal Pharma, Inc.

1.8700

+6.86%

TTOO T2 Biosystems, Inc.

4.1600

-5.24%

GHSI Guardion Health Sciences, Inc.

8.50

+3.28%

SINT Sintx Technologies, Inc.

0.0550

+41.75%

OPGN OpGen, Inc.

0.4420

+0.45%

NAOV NanoVibronix, Inc.

0.7152

-3.35%

EDSA Edesa Biotech, Inc.

4.5300

+3.66%

VYNE VYNE Therapeutics Inc.

2.8900

+3.21%

NDRA ENDRA Life Sciences Inc.

0.2897

-1.13%

EQ Equillium, Inc.

1.5400

0.00%